NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (59)
2023
-
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival
Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703
-
The complex HLA-E-nonapeptide in Behçet disease
Frontiers in Immunology, Vol. 14
2022
-
Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E180-E188
-
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)
Scientific Reports
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Scientific reports, Vol. 12, Núm. 1, pp. 5289
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
2021
-
Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)
Scientific Reports
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
Multiple vertebral fractures after suspension of denosumab. A series of 56 cases
International Journal of Clinical Practice, Vol. 75, Núm. 10
-
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Longterm efficacy and safety of monotherapy versus combination therapy in systemic sclerosis-associated pulmonary arterial hypertension: A retrospective RESCLE registry study
Journal of Rheumatology, Vol. 47, Núm. 1, pp. 89-98
-
Serodiscordant patients with systemic sclerosis: When antibody does not correspond to skin involvement
Clinical and Experimental Rheumatology, Vol. 38, pp. S106-S114
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5